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In both invertebrates and vertebrates, transcriptional co-re-
pressors of theGroucho/transducin-like Enhancer of split (Gro/
TLE) family regulate a number of developmental mechanisms,
including neuronal differentiation. The pleiotropic activity of
Gro/TLEdependson context-specific interactionswith a variety
of DNA-binding proteins. Most of those factors engage Gro/
TLE through two different types of short peptide motifs, the
WRP(W/Y) tetrapeptide and the Engrailed homology 1 (Eh1)
sequence (FXIXXIL). The aim of this study was to elucidate the
contribution ofWRP(W/Y) and Eh1motifs to mammalian Gro/
TLE anti-neurogenic activity. Here we describe pointmutations
within the C-terminal WD40 repeat domain of Gro/TLE1 that
do not perturb protein folding but disrupt the ability of Gro/
TLE1 to inhibit the differentiation of cerebral cortex neural
progenitor cells into neurons. One of thosemutations, L743F,
selectively blocks binding to Hes1, an anti-neurogenic basic
helix-loop-helix protein that harbors aWRPWmotif. In con-
trast, the L743F mutation does not disrupt binding to
Engrailed1 and FoxG1, which both contain Eh1 motifs, nor to
Tcf3, which binds to the Gro/TLE N terminus. These results
demonstrate that the recruitment of transcription factors
harboring WRP(W/Y) tetrapeptides is essential to the anti-
neurogenic function of Gro/TLE1.
Transcriptional co-repressors of the Groucho/transducin-
like Enhancer of split (Gro/TLE)3 family play critical roles dur-
ing multiple developmental processes, including neuronal dif-
ferentiation in the developing mammalian forebrain (1). Gro/
TLEs act as co-repressors for a variety of DNA-binding
transcription factors. Some of those proteins are dedicated tran-
scriptional repressors while othersmediate repression or transac-
tivation depending on specific contexts (1–4). Through interac-
tions with a large number of transcriptional regulators, Gro/
TLEs are involved in the gene regulatory functions of a variety
of signaling pathways, including Notch, Wnt/Wingless, trans-
forming growth factor- superfamily, and epidermal growth
factor receptor signal transduction mechanisms (1–6). More-
over, growing evidence suggests important roles for Gro/TLEs
in integrating these different signaling cascades during several
developmental processes (1, 5).
The regulation of neuronal differentiationwas one of the first
functions ofGro/TLEproteins to be characterized.DuringDro-
sophila neural development, Gro participates in theNotch-me-
diated lateral inhibition mechanism that restricts the number
of committed neuroblasts within proneural clusters containing
initially equipotential presumptive neural progenitor cells (7,
8). Neuroblasts undergoing commitment activate the Notch
receptor in adjacent cells, resulting in the transcriptional induc-
tion of genes encoding basic helix loop helix (bHLH) proteins of
the Hairy/Enhancer of split (Hes) family. These DNA-binding
proteins recruit Gro to form complexes that repress the expres-
sion, as well as biochemical activity, of proteins that promote
neuronal differentiation, like the bHLH factors encoded by
achaete-scute complex and atonal genes (9–11). Loss-of-func-
tion mutations ofDrosophila gro result in the differentiation of
supernumerary neurons, similar to the phenotype caused by
disruption of Notch or Enhancer of split genes (7, 8).
MammalianGro/TLEproteins also perform anti-neurogenic
functions. Gro/TLE1 and Gro/TLE3 are expressed in undiffer-
entiated neural progenitor cells of the ventricular zone of the
telencephalic vesicles (12–14). Forced expression of Gro/TLE1
in the forebrain of transgenicmice causes an inhibition/delay of
neuronal development in vivo (15). Similarly, exogenous
expression ofGro/TLE1 in primary cultures of undifferentiated
neural progenitor cells from the dorsal telencephalon causes
decreased neuronal differentiation and an accumulation of pro-
liferating progenitor cells (14).
The molecular mechanisms underlying Gro/TLE-mediated
inhibition of neuronal differentiation in the mammalian fore-
brain remain to be defined. Gro/TLEs form complexes, and
repress transcription, with a number of DNA-binding proteins
expressed during forebrain neuronal differentiation. These
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include, but are not limited to, bHLHproteins of theHes family,
like Hes1 (10, 14, 16, 17), forkhead box proteins, such as FoxG1
(18–20), and homeodomain proteins of the Six (21, 22), Pax
(23), andOtx (24) families. Most transcription factors that bind
to Gro/TLE interact with the C-terminal WD40 repeat (WD)
domain of the latter and can be grouped into two main classes
based on the fact that they utilize two different types of short
peptide sequences to recruit Gro/TLE co-repressors. Those
“repressor peptides” belong to either the WRP(W/Y) (termed
WRPW hereafter) or Engrailed homology 1 (Eh1; FXIXXIL)
motif families (1). Although different in sequence, bothWRPW
and Eh1 peptides bind to an overlapping, but not completely
identical, site on the surface of the Gro/TLEWD domain (25).
Here we describe studies aimed at determining the contribu-
tion of different groups of transcription factors to the ability of
Gro/TLE1 to inhibit the differentiation of cerebral cortex (cor-
tical) neural progenitor cells into neurons. Our results show
that Gro/TLE1 recruitment via repressor peptides of the
WRPWfamily is essential forGro/TLE1-mediated inhibition of
neuronal differentiation. In contrast, the ability to interact with
proteins that either contain repressor peptides of the Eh1 type
or bind to the Gro/TLE N terminus is not sufficient to mediate
Gro/TLE1 anti-neurogenic function. These results character-
ize the mechanisms underlying Gro/TLE1 activity during cor-
tical neurogenesis.
EXPERIMENTAL PROCEDURES
Site-directed Mutagenesis and DNA Plasmids—DNAs
encoding mutated forms of Gro/TLE1 harboring the muta-
tions V486S, C488R, R534A, E550K, and L743F were gener-
ated by site-directed mutagenesis using the QuikChange II
site-directed mutagenesis kit (Stratagene, La Jolla, CA),
using pCMV2-FLAG-Gro/TLE1 (14) as substrate. Oligonu-
cleotide primers used for mutagenesis were as follows
(mutations are underlined): V486S-F: 5-CAACCACGGGG-
AGTCGGTGTGCGCTGTGA, C488R-F: 5-CGGGGAGG-
TGGTGAGAGCTGTGACCATCAGC, R534A-F: 5-CTG-
AACAGAGACAATTATATCGCTTCCTGTAAATTGCT-
ACCCG, E550K-F: 5-CTCATAGTGGGAGGGAAAGCCAG-
TACTTTGTCC, and L743F-F: 5-GAGTCCTCGTCAGTGT-
TTAGCTGTGACATCTC. pcDNA3-GAL4dbd-Gro/TLE1
plasmids were generated by amplifying by PCR the entire cod-
ing sequence of each mutant using the appropriate pCMV2-
FLAG-Gro/TLE1 plasmids as template, followed by subcloning
into the EcoRV site of pcDNA3-GAL4dbd plasmid, which
encodes the DNA-binding domain of GAL4 (GAL4dbd).
Vectors pEBG-Hes1, pEBG-Hes1(WRPW), pEGFP, pCMV2-
FLAG-Gro/TLE1, pCMV2-HA-FoxG1, pMyc-Tcf3, pCMV2-
HA-En1, p5xGAL4UAS-SV40p-luciferase, and pRSV--ga-
lactosidase were described (14, 16, 18, 20).
Transcription Assays—For studies using a GAL4-responsive
promoter, HEK293 cells were transfected using the SuperFect
reagent (Qiagen) as described (14, 20). The total amount of
transfected DNA was adjusted in each case at 3 g per well
using pcDNA3. Transcription assays were performed using 1.5
g/well of reporter construct p5xGAL4UAS-SV40p-luciferase
in the presence or absence of plasmids pcDNA3-GAL4dbd or
pcDNA3-GAL4dbd-Gro/TLE1 (WT, V486S, C488R, R534A,
E550K, or L743F) (1.0 g/well). In each case, 0.5 g/well of
-galactosidase expression plasmid, pRSV--gal, was used to
normalize for transfection efficiency. Twenty-four hours after
transfection, cells were subjected to determination of luciferase
activity as described (14, 16, 19, 26). Results were expressed as
mean values S.D. Expression of GAL4dbd-Gro/TLE1 fusion
proteins was detected using an anti-Gro/TLE1 antibody
(1:1,000) (14).
Interaction Assays in Transfected Cells and Western Blotting
Analysis—HEK293 cells were cultured and transfected using
SuperFect. In each experiment, cells were co-transfected with
1.0 g of pCMV2-FLAG-Gro/TLE1 (WT, V486S, C488R,
R534A, E550K, or L743F) and 1.0 g of either pEBG-HES1 (or
pEBG-HES1(WRPW) as control), pCMV2-HA-FoxG1, pMyc-
Tcf3, or pCMV2-HA-En1. Cell lysates were prepared and GST
co-precipitations or co-immunoprecipitations using either
anti-HA (Covance, Berkeley, CA) or anti-Gro/TLE1 (14) anti-
bodies were performed as described (14, 20, 27). This was fol-
lowed byWestern blotting analysis using anti-FLAG (1:10,000;
Sigma), anti-GST (1:500; Santa Cruz Biotechnology, Santa
Cruz, CA), anti-HA (1:5,000), or anti-Myc (1:200; BD Pharm-
ingen, San Diego, CA) antibodies.
Cortical Neural Progenitor Cell Cultures—Primary cultures
of neural progenitor cells were established from dorsal telence-
phalic cortices dissected from embryonic day (E) 12–14 mouse
embryos as described (27–31). Cells were seeded into four-well
chamber slides (Nalgene Nunc, Rochester, NY) coated with
0.1% poly-D-lysine and 0.2% laminin (BD Biosciences, Bedford
Park,MD), cultured inNeurobasalmedium supplementedwith
1% N2, 2% B27, 0.5 mM glutamine, 1% penicillin-streptomycin
(Invitrogen), and 40 ng/ml of FGF2 (Collaborative Research,
Bedford, MA). After 48 h in vitro, cells were transfected with
plasmids encoding either enhanced green fluorescent protein
(GFP) alone (0.2 g/well), or both GFP (0.2 g/well) and Gro/
TLE1 (pCMV2-FLAG-Gro/TLE1 (WT, V486S, C488R, R534A,
E550K, or L743F)) (0.8 g/well). When needed, the total
amount of DNA was adjusted to 1.0 g using pcDNA3. DNA
was mixed with 50 l of OptiMEM medium (Invitrogen), fol-
lowed by incubation for 5 min. An equal volume of OptiMEM
medium were mixed separately with Lipofectamine 2000 rea-
gent (Invitrogen; 2 l/g of DNA) and then combined with the
DNA mixture and incubated for 20 min at room temperature.
The DNA-Lipofectamine 2000 mixture was then added drop-
wise to each well. Three days later, cells were fixed and sub-
jected to immunocytochemistry using antibodies against the
proliferating cell marker Ki67 (1:200; BD Pharmingen), the
neural progenitor cell marker nestin (1:400; Chemicon,
Temecula, CA), the neuronal cell marker III-tubulin (1:300;
Promega), the neuronal cell marker neuron specific nuclear
protein (NeuN) (1:100; Chemicon), the astrocyte cell marker
glial fibrillary acidic protein (GFAP; 1:300; Sigma), or activated
caspase-3 (1:200; BD Pharmingen). Cells were counterstained
with Hoechst 33258 (Sigma) before examination by fluores-
cence microscopy (14, 27, 31). Grayscale images were digitally
assigned to the appropriate red or green channel using North-
ern Eclipse software (Empix, Ontario, Canada). Three to six
random fields of each condition (per experiment) were used for
quantitation of the percent of GFP-positive cells co-expressing
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specific markers (28–31) Results were expressed as the mean
values S.D. At least six separate experiments were conducted
in each case, and statistical analysis was performed using the
Student’s t-test.
RESULTS
Characterization of Point Mutations in the WD Domain of
Gro/TLE1 That Do Not Disrupt Protein Folding—Previous
mutation and structural studies ofWDdomain containing pro-
teins like -transducin repeat-containing protein 1 (32), the
-subunit ofGprotein-coupled receptors (33, 34), and the yeast
Gro/TLE analogue Tup1 (35) have revealed that residues impli-
cated in protein-protein interactions are preferentially located
at similar positions on the external surface surrounding the
central channel of the-propeller.Multiple blades and residues
are implicated in those interactions. More specifically, surface
residues located at the start of the first -sheet or just after the
second one are often implicated in protein-protein interactions
(32).
In agreement with those findings, analysis of the crystal
structure of the Gro/TLE1WD domain demonstrated that one
side of the central pore of the -propeller harbors overlapping
binding sites for bothWRPWand Eh1 peptides (25). This com-
mon transcription factor-binding pocket contains key surface
residues located within separate blades of the -propeller.
Some of those residues are essential for interaction with both
WRPWand Eh1 peptides, while others are required for binding
to the former but not the latter (25).
The crystal structure of the WD domain of Gro/TLE1 (25,
36) was utilized in conjunction with naturally occurring muta-
tions at evolutionarily conserved residues in Gro/TLE-related
proteins such as Drosophila Gro (25), Caenorhabditis elegans
UNC-37 (37, 38), and yeast Tup1 (35, 39) to select five residues
within the WD domain of Gro/TLE1 as in vitro mutagenesis
targets (Fig. 1, A–C). More specifically, we generated the fol-
lowing mutations: V486S (similar to the Gro mutations V435A
and V435L), C488R (analogous to mutations C348R in Tup1
and C437M in Gro), R534A (analogous to mutation R483H in
Gro), E550K (analogous tomutations E463N inTup1, E394K in
UNC-37, and E499A in Gro), and L743F (analogous to muta-
tion L692F in Gro) (Fig. 1D).
Based on crystallographic data (25, 36), thesemutationswere
not expected to disrupt the overall structure of theWDdomain.
In agreement with this prediction, we observed that all mutated
proteins migrated on denaturing polyacrylamide gels like wild-
typeGro/TLE1 (Fig. 1E), were able to translocate to the nucleus
(Fig. 1F), and retained the ability to repress transcription from a
basally active promoter when expressed as fusion proteins with
the DNA-binding domain of the yeast protein GAL4 (Fig. 2).
Together, these results demonstrate that the pointmutations in
the WD domain of Gro/TLE1 selected for this study do not
significantly perturb the structure and biochemical activity of
Gro/TLE1.
Different Effects ofWDDomainMutations on theAbility ofGro/
TLE1 to Interact with WRPW or Eh1 Repressor Peptides—To
assess the possible effects of the WD domain mutations on the
anti-neurogenic activity of Gro/TLE1, we first determined
whether they would block Gro/TLE1 interaction with different
FIGURE 1. Characterization of Gro/TLE1 WD domain mutations. A, sche-
matic representation of the Gro/TLE1 C-terminal -propeller composed of
seven blades each consisting of a four-stranded -sheet (36). B, surfacemap-
ping and electrostatic potential representation of the -propeller (color cod-
ing: red for negative charges and blue for positive charges) showing charged
residues surrounding the predicted central hydrophilic channel where
WRW(P/Y) and Eh1 repressor peptides bind. C, mapping of the five point
mutations (V486S, C488R, R534A, E550K, and L743F) introduced in the Gro/
TLE1WDdomain, shown in red.D, list ofmutations analyzed in this study and
equivalent mutations in Drosophila Gro, C. elegans UNC-37, and yeast Tup1.
E, Western blotting (WB) analysis using an anti-FLAG antibody of WT or
mutated forms of FLAG epitope-tagged Gro/TLE1 proteins expressed in
HEK293 cells. F, nuclear localization of wild-type or mutated Gro/TLE1 pro-
teins determined by immunofluorescence analysis of transfected HEK293
cells using an anti-FLAG antibody.
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transcription partners. Several Gro/TLE-binding factors that
contain either WRPW or Eh1 motifs are expressed during cor-
tical neuron development in cells where Gro/TLE1 is also
expressed (18, 21–24). We therefore selected specific Gro/
TLE1 transcription partners that would represent examples of
different categories of proteins. The bHLH factor Hes1 was
selected as a prototypicalWRPWmotif-bearing protein.More-
over, Hes1 is a critical regulator of cortical neurogenesis (40–
42). Engrailed1 (En1) was chosen as a typical example of a pro-
tein that uses an Eh1 motif to recruit Gro/TLE proteins (43).
We also examined Tcf3, as an example of a transcription part-
ner that interactswith theN terminus, andnot theWDdomain,
of Gro/TLE (44).
Co-transfections followed by pull-down (Fig. 3A) or co-im-
munoprecipitations (Fig. 3, B and C) assays showed that sepa-
rateWDmutations had different effects onGro/TLE1 ability to
interact with those proteins. All mutations completely blocked
or severely reduced the interaction with Hes1 (Fig. 3A), sug-
gesting that each of those residues is important for optimal
WRPW peptide recognition. In contrast, the interaction of
Gro/TLE1 with En1 was disrupted only by mutations C488R,
R534A, and E550K, but not by the V486S and L743Fmutations
(Fig. 3B). These findings show thatWRPW- and Eh1motif rec-
ognition by the WD domain of Gro/TLE1 is mediated by both
overlapping and separate residues. In particular, the contribu-
tion of Leu-743 is essential forWRPW peptide binding but not
for Eh1 motif recognition. In contrast to the results with Hes1
and En1, all Gro/TLE1 WD mutations retained the ability to
bind to Tcf3 (Fig. 3C). In agreement with this finding, each
mutated protein repressed trans-activation mediated by
-catenin/Tcf complexes in transfected cells (data not shown).
These results are consistent with the notion that Tcf/Lef pro-
teins interact with the N-terminal domain of Gro/TLE (44).
We next examined the ability of mutated Gro/TLE1 proteins
to bind to the forkhead transcription factor FoxG1, which is a
critical regulator of telencephalic neurogenesis (45). Previous in
vitro studies have suggested that Gro/TLE1 binds to FoxG1
FIGURE 2. Analysis of transcription repression activity of wild-type and
mutated Gro/TLE1 proteins. A, HEK293 cells were transfected with a
p5xGAL4UAS-SV40p-luciferase reporter construct (1.5 g/transfection) in the
absence (bar 1) or presence of WT (bar 2) or mutated (bars 3–7) forms of
GAL4dbd-Gro/TLE1 (1 g/transfection). Basal luciferase activity in the
absence of effector plasmids was considered 100%, and values in the pres-
ence of effector plasmids were expressed as themean S.D. of at least three
separate experiments performed in duplicate; *, p 0.001. B, Western blot-
ting (WB) analysis of Gro/TLE1 proteins used in the transcription assays using
anti-Gro/TLE1 antibody. GAL4dbd-Gro/TLE1 consistently migrated as a dou-
blet; the migration of this doublet was slower than endogenous Gro/TLE1
(see arrow). The level of expression of exogenous GALdbd-Gro/TLE1 proteins
was similar to that of endogenous Gro/TLE1.
FIGURE 3. Effect of different Gro/TLE1WD domainmutations on interac-
tion with Hes1, En1, or Tcf3. A, HEK293 cells were co-transfected with plas-
mids encoding FLAG epitope-tagged WT or mutated Gro/TLE1 and either a
fusion protein of GST and full-length Hes1 (lanes 1–6) or truncated Hes1 lack-
ing theWRPWmotif required for Gro/TLE binding (WRPW) (lane 7). Each cell
lysate (INPUT) was incubatedwith glutathione-Sepharose beads and the pre-
cipitated material (PD, pull-down), together with 1:10 of each input lysate,
was subjected to Western blotting (WB) analysis with anti-FLAG or anti-GST
antibodies. B and C, HEK293 cells were co-transfected with plasmids encod-
ing FLAG epitope-tagged wild-type or mutated Gro/TLE1 proteins, as indi-
cated, and eitherHAepitope-tagged En1 (B) orMyc epitope-tagged Xenopus-
Tcf3 (C). Each cell lysate (INPUT) was subjected to immunoprecipitation (IP)
with either anti-HA (B) or anti-Gro/TLE1 (C) antibodies. Immunoprecipitates,
together with 1:10 of each input lysate, were analyzed by Western blotting
with the indicated antibodies.
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using both its C-terminal WD domain and N-terminal Q
domain (18). This possibility is consistent with the presence of
both a putative Eh1 motif (FSINSLV) at the N terminus of
FoxG1 and a separate Gro/TLE binding sequence at a more
C-terminal location (18, 19), suggesting that FoxG1 uses mul-
tiple sequences to engage Gro/TLE1. Co-immunoprecipitation
studies showed thatmutations E550K and L743F did not signif-
icantly affect the Gro/TLE1 ability to bind to FoxG1 (Fig. 4A).
The other mutations reduced but did not completely block this
interaction. These observations suggest that the mode of Gro/
TLE1 recruitment by FoxG1 is complex and involves separate
domains. Nevertheless, the observation that FoxG1 still inter-
acts with the L743F mutant suggests further that Leu-743 is
critical for binding to WRPW peptides but not other Gro/TLE
binding sequences.
Analysis of Gro/TLE1 proteins on low percentage polyacryl-
amide gels allowed the resolution of separateGro/TLE1 species
with different electrophoretic mobility (Fig. 4A, lanes 1–7, and
Fig. 4B). Reduced electrophoretic mobility of Gro/TLE1 has
been shown previously to result from increased phosphoryla-
tion, a process that is promoted by interaction with several
transcription partners, including FoxG1, and is referred to as
“cofactor-activated phosphorylation” (14, 16). We found that
mutations that reduced binding to FoxG1, such as V486S,
C488R, and R534A, also reduced the increased phosphoryla-
tion of Gro/TLE1 observed in the presence of FoxG1 (Fig. 4B,
see lanes 2–5). Importantly, mutation E550K, which does not
prevent binding to FoxG1, com-
pletely blocked the cofactor-acti-
vated phosphorylation of Gro/TLE1
(Fig. 4B, lane 6). These findings sug-
gest an essential role for Glu-550 in
the regulation of Gro/TLE1 phos-
phorylation, possibly by mediating
protein-protein interactions with
critical factors.
Taken together, these results sug-
gest that different WD domain
mutations provide a usefulmeans of
uncoupling transcription repres-
sion partner recognition, permit-
ting the examination of the specific
contributions of separate protein
classes to the biological functions of
Gro/TLE1.
Requirement for WRPW Motif
Recruitment for Gro/TLE1 Anti-neu-
rogenic Activity—Forced expression
of Gro/TLE1 inhibits/delays corti-
cal neuron differentiation in the
telencephalon of developing trans-
genic mouse embryos and cultures
of cortical neural progenitor cells
(14, 15). To clarify the contribution
of transcription factors containing
WRPW or Eh1 motifs to its anti-
neurogenic function, we exog-
enously expressed wild-type or
mutated Gro/TLE1 proteins in primary cultures of neural pro-
genitor cells obtained from dissected dorsal telencephalon
from E12-E14 mouse embryos (Fig. 5, A and B). This defined
primary culture system (“cortical progenitor cells”) has been
used on multiple occasions to investigate the functions of
extrinsic and intrinsic regulators of cortical neuron differenti-
ation (27–31, 46–49). Enhanced GFP was co-expressed with
Gro/TLE1 to visualize the transfected cells, which were ana-
lyzed for the expression of markers of proliferating cells, undif-
ferentiated neural progenitors, postmitotic neurons, or astro-
cytes after 5 days in vitro (Fig. 5B and data not shown). As
previously described (14), exogenous expression of wild-type
Gro/TLE1 resulted in an increase in the number of cells co-
expressing GFP and the mitotic cell marker Ki67, compared
with control (Fig. 5C). Wild-type Gro/TLE1 caused a similar
increase in the number of nestin-positive neural progenitor
cells (Fig. 5D). These effects were accompanied by a significant
reduction in the number of GFP-positive cells exhibiting a neu-
ronal morphology and expressing the neuronal cell markers,
NeuN and III-tubulin (Fig. 5, F and G). GFAP-positive astro-
cytes accounted for a small fraction of the cells in culture and
Gro/TLE1 expression had no detectable effect on their number
(Fig. 5E). The number of transfected cells showing signs of pro-
grammed cell death, like the expression of activated caspase-3,
was small under all conditions tested (Fig. 5H). These results
show a role for Gro/TLE1 in delaying/inhibiting the differenti-
ation of cortical progenitor cells into neurons.
FIGURE 4. Effect of different Gro/TLE1WD domain mutations on interaction with FoxG1. A, HEK293 cells
were co-transfected with plasmids encoding FLAG epitope-taggedWT or mutated Gro/TLE1 proteins, as indi-
cated, and FLAG-tagged FoxG1. Each cell lysate (INPUT) was subjected to immunoprecipitation (IP) with an
anti-Gro/TLE1 antibody. Immunoprecipitates, together with 1:10 of each input lysate, were subjected to SDS-
polyacrylamide gel electrophoresis on either 6% (lanes 1–8) or 10% (lanes 9–14) gels, followed by Western
blotting (WB)with ananti-FLAGantibody.B, HEK293 cellswere co-transfectedwith the indicated combinations
of proteins, followedby fractionation of cell lysates on a 6%SDS-polyacrylamide gel andWestern blottingwith
an anti-FLAG antibody. Asterisks are placed next to the slower form of Gro/TLE1 observed in selected cases in
the presence of FoxG1.
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The anti-neurogenic effect of
Gro/TLE1 was abolished by muta-
tions that selectively disrupt inter-
action with WRPW, but not Eh1,
repressor peptides, such as V486S
and L743F (Fig. 5,C andD, F andG).
The E550K mutation, which pre-
vents interactionwithHes1 and En1
but does not block binding to
FoxG1, also abrogated the anti-neu-
rogenic affect ofGro/TLE1 (Fig. 5,C
and F). The samewas true formuta-
tions, like C488R and R534A, which
disrupt the interaction of Gro/TLE1
with Hes1, En1, and Foxg1, but not
Tcf3 (Fig. 5,C andD, F andG). None
of the mutated Gro/TLE1 proteins
caused significant changes in the
number of cells expressing GFAP or
activated caspase-3 (Fig. 5, E andH).
Taken together, these results indi-
cate that the anti-neurogenic activ-
ity of Gro/TLE1 depends on the
recruitment of WRPWmotif family
proteins. They suggest further that
Hes family members are the pri-
mary anti-neurogenic partners of
Gro/TLE1 during cortical neuron
development.
DISCUSSION
In this report, we sought to deter-
mine whether the ability of Gro/
TLE1 to inhibit/delay the transition
of cortical progenitor cells into neu-
rons depends on interactions with
proteins containing the WRPW
or/and Eh1 repressor peptides, or
neither of those. By analyzing a
panel ofWDdomainmutations that
selectively impair the interaction of
Gro/TLE1 with different transcrip-
tional cofactors, we have shown that
WRPW motif recognition is essen-
tial for Gro/TLE1 anti-neurogenic
activity.
Essential Role of Specific WD
Domain Residues in Repressor Pep-
tide Recognition—Using informa-
tion derived from previous struc-
tural and genetic studies, we
generated a panel of point muta-
tions within the C-terminal WD
domain of Gro/TLE1 that do not
disrupt the overall structure of this
-propeller, as indicated by the abil-
ity of the mutated proteins to trans-
locate to the nucleus and repress
FIGURE5.EffectofGro/TLE1proteinsoncortical neurondifferentiation.A, primary culturesof E13.0mouse
embryonic cortical progenitor cells were transfected with plasmids encoding FLAG-tagged forms of Gro/TLE1
(lanes 2–7), followed by immunoprecipitation (IP) and Western blotting (WB) analysis of the transfected pro-
teins with anti-FLAG antibody; untransfected cells were analyzed in lane 1. B, cortical progenitor cells were
transfected with either GFP alone (Control, top row) or a combination of GFP and wild-type Gro/TLE1 (middle
row), Gro/TLE1L743F (bottom row), or other mutated forms of Gro/TLE1 (not shown). Approximately 48 h later,
cells were fixed and subjected to double-labeling analysis of the expression of GFP (green) and either the
progenitor cellmarkers Ki67 andnestin, theneuronalmarkersNeuNandIII-tubulin (red), the astrocytemarker
GFAP or activated caspase-3 (not shown). Arrowheads point to examples of double-labeled cells. C–H, quanti-
tation of the percentage of GFP-positive cells that also expressed the indicated markers. Results are shown as
themean S.D. (500 cells were counted in each case; n 6; *, p 0.001 using the Student’s t test). F and G,
III-tubulin immunoreactivity marks both younger and older neuron populations, whereas NeuN immunore-
activity labels preferentially more mature neurons. As a result, larger numbers of neurons are detected using
the anti-III-tubulin antibody compared with the anti-NeuN antibody.
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both basal and activated transcription in transfected cells.
These mutations can be grouped into two categories based on
their effect on repressor peptide recognition. One group (cate-
gory-1 mutations) disrupts interactions with both WRPW and
Eh1 peptideswhereas the second (category-2) blocks binding to
the former but not the latter.
Mutations C488R, R534A, and E550K behaved as category-1
mutations in our study. Those three residues sit near themouth
of the central pore of the -propeller (25, 36) and participate in
key interactions with the C-terminal tryptophan, N-terminal
tryptophan, and arginine of the WRPW peptide, respectively
(25). In the case of the Eh1 motif (FXIXXIL), those residues
make key contacts with leucine 7, phenylalanine 1, and isoleu-
cine 3, respectively (25). The essential roles of those amino
acids are further highlighted by their evolutionary conservation
amongGro/TLE orthologs and analogs and the severe effects of
naturally occurring mutations at those sites. More specifically,
amino acid positions corresponding to Glu-550 in Gro/TLE1
are conserved inDrosophilaGro (Glu-499),C. elegansUNC-37
(Glu-394), and yeast Tup1 (Glu-463). Mutations targeting this
position were found for Tup1 (E463N) (39) and UNC-37
(E394K) (38). In both cases, these mutations significantly per-
turb the biological functions of these proteins. Similarly, the
position equivalent to Arg-534 of Gro/TLE1 is mutated
(R483H) in a Drosophila gro allele that causes widespread per-
turbation of the embryonic functions of this gene (25). Taken
together, these observations are consistent with the notion that
category-1 residues are critical for Gro/TLE protein ability to
engage a large number of transcription partners.
We have found that V486S and L743F behave as category-2
mutations. Those residues are part of a hydrophobic recess
located at the mouth of the central pore, and are involved in
interactionswith the side chain of theC-terminal tryptophan of
theWRPWpeptide (25). This hydrophobic depression appears
to be flexible enough to accommodate the equally flexible side
chains of isoleucine-3, isoleucine-6, and leucine-7 of the Eh1
motif even in the presence of Val-486 or Leu-743 mutations
(this study and Ref. 25). Analysis in Drosophila shows that
mutation of Leu-629 (equivalent to Leu-743 of Gro/TLE1)
causes embryonic phenotypes that are somewhat weaker than
those resulting from mutations of WD domain residues
required for interactions with both WRPW and Eh1 peptides
(25), consistent with only a partial perturbation of protein-pro-
tein interactions.
The effects of theWDdomainmutations on cofactor binding
do not seem to be due to a generalizedmisfolding of Gro/TLE1,
because all the mutated proteins were competent to interact
with, and repress trans-activation mediated by, Tcf proteins.
These observations suggest further that thosemutations should
not cause a generalized loss of themany functions ofGro/TLE1,
as they are not predicted to affect all of its protein-protein inter-
actions. It should be noted, however, that we cannot rule out
the possibility that at least some of those mutations might dis-
rupt interactions with global cofactors that bind to the WD
domain and are required by most, if not all, transcription part-
ners, including those that bind to the N terminus of Gro/TLE1.
Uncoupling of Repressor Peptide Recognition Reveals an
Essential Role for WRPWMotif Recognition in Gro/TLE1 Anti-
neurogenic Activity—The present studies show that category-1
mutations, which block Gro/TLE1 ability to interact with both
WRPW and Eh1 peptides, also disrupt its inhibitory effect on
cortical neuron differentiation. Category-2 mutations, which
do not prevent binding to proteins that harbor an Eh1 motif
(like En1 or FoxG1) or proteins that bind exclusively to the
Gro/TLE1 N-terminal Q domain (like Tcf3), also disrupt Gro/
TLE1 anti-neurogenic function. These results indicate that the
ability to become recruited by transcription factors that either
belong to the Eh1 peptide group or engage Gro/TLE via the
N-terminal region of the latter is not sufficient to mediate Gro/
TLE1 anti-neurogenic activity. Thus, even though members of
these protein groups are expressed in forebrain progenitor
cells, they do not appear to be involved in Gro/TLE1-mediated
inhibition of cortical neurogenesis. Instead, our findings show
that Gro/TLE1 depends on interactions with proteins contain-
ingWRPWmotifs to inhibit the cortical progenitor-to-neuron
transition.
This interpretation agrees with several previous findings.
Hes1 (a prototypical WRPW motif protein) and Gro/TLE are
co-expressed in cortical neural progenitor cells, form com-
plexes, and repress transcription together (14, 16, 18, 20).
Moreover, bothHes1 andGro/TLE1were shown to associate in
cultured neural stem cells with the promoter of pro-neuronal
genes, like Mash1 (17). Misexpression of Gro/TLE1 in the
developing forebrain causes reduced neuronal differentiation
in vivo, as does its exogenous expression in cultured cortical
neural progenitor cells (Refs. 14, 15 and this study). These
effects are similar to the inhibition of neuronal differentiation
and maintenance of neural stem/progenitor cells caused by
misexpression of Hes1, Hes3, or Hes5 in the embryonic brain
(41, 50, 51). Conversely, Hes1;Hes5 double knock-out mice
show a premature differentiation of neural stem/progenitor
cells into neurons (52). Together with our present findings,
these results strongly suggest that Gro/TLE1 works together
with Hes proteins to regulate the transition of cortical neural
progenitor cells into neurons.
The physiological significance of the ability of Gro/TLE1 to
form complexes with other factors expressed during cortical
neurogenesis remains to be defined. It is possible that through
such interactions Gro/TLE1 might participate in mechanisms
important for other cellular processes, like the regulation of the
rate of cell proliferation of neural progenitors, or the specifica-
tion of selected neuronal fates. In that regard, previous studies
have shown that different Gro/TLE family members continue
to be expressed in different populations of post-mitotic cortical
neurons, suggesting non-overlapping roles in the establishment
and/or maintenance of neuronal identity (47, 53).
Gro/TLE family members regulate a large number of devel-
opmental processes. The availability of mutations that selec-
tively perturb interactions with specific families of Gro/TLE
transcription partners is expected to facilitate the elucidation of
themolecularmechanisms underlying the pleiotropic activities
of this family of transcriptional co-repressors.
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